Futuximab

Tax included
Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity.
MedChemExpress 
HY-P99628

Data sheet

Size
Multiple sizes
Reactivity
EGFR
Application
Cancer-programmed cell death
CAS
1310460-85-5